, Tracking Stock Market Picks
Enter Symbol:
Rating: ORPN
Buy $25

Bio Blast Pharma Ltd. (NASDAQ: ORPN) rated to Buy with price target $25 by Rodman & Renshaw

Thursday,  Jan 28, 2016  8:25 AM ET by Betsy O'Brien Harrison

Rodman & Renshaw rated Bio
Blast Pharma Ltd. (NASDAQ: ORPN) to Buy with price target $25.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy